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Abstract
Introduction: Inflammatory arthritis is a progressive disease with chronic inflammation of joints, which is mainly
characterized by the infiltration of immune cells and synovial hyperproliferation. Monocytes migrate towards
inflamed areas and differentiate into macrophages. In inflamed tissues, much lower oxygen levels (hypoxia) are
present in comparison to the peripheral blood. Hence, a metabolic adaptation process must take place. Other
studies suggest that Hypoxia Inducible Factor 1-alpha (HIF-1a) may regulate this process, but the mechanism
involved for human monocytes is not yet clear. To address this issue, we analyzed the expression and function of
HIF-1a in monocytes and macrophages, but also considered alternative pathways involving nuclear factor of kappa
light polypeptide gene enhancer in B-cells (NFB).
Methods: Isolated human CD14+ monocytes were incubated under normoxia and hypoxia conditions with or
without phorbol 12-myristate 13-acetate (PMA) stimulation, respectively. Nuclear and cytosolic fractions were
prepared in order to detect HIF-1a and NFB by immunoblot. For the experiments with macrophages, primary
human monocytes were differentiated into human monocyte derived macrophages (hMDM) using human
macrophage colony-stimulating factor (hM-CSF). The effects of normoxia and hypoxia on gene expression were
compared between monocytes and hMDMs using quantitative PCR (quantitative polymerase chain reaction).
Results: We demonstrate, using primary human monocytes and hMDM, that the localization of transcription factor
HIF-1a during the differentiation process is shifted from the cytosol (in monocytes) into the nucleus (in
macrophages), apparently as an adaptation to a low oxygen environment. For this localization change, protein
kinase C alpha/beta 1 (PKC-a/b1 ) plays an important role. In monocytes, it is NFB1, and not HIF-1a, which is of
central importance for the expression of hypoxia-adjusted genes.
Conclusions: These data demonstrate that during differentiation of monocytes into macrophages, crucial cellular
adaptation mechanisms are decisively changed.
Introduction
Inflammatory arthritis is characterized by infiltration of
immune cells and local tissue hypoxia [1-3]. Mature
monocytes migrate towards sites of inflammation and
infection where they differentiate into inflammatory
macrophages or into dendritic cells (DCs) [1,4,5].
Macrophages have the highest phagocytic potential of
cells in the area of inflammation. They also present the
antigen components previously processed via the major
histocompatibility complex II (MHC II) and, via cyto-
kines, attract other macrophages, granulocytes and
T-cells into inflamed areas.
Monocytes and macrophages require energy in the
form of adenosine triphosphate (ATP) in order to facili-
tate motion (migration to achieve phagocytosis), activa-
tion (signal cascade, initiation, maintenance, cytokine
production) and effector functions (phagocytosis, antigen
presentation, regulatory functions) [4]. Under aerobic
conditions, the energy supply of the cells occurs via oxi-
dative phosphorylation (OxPhos) and glycolysis. In the
absence of oxygen (that is, under hypoxic conditions),
OxPhos does not occur and only glycolysis remains for
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ATP production, because this process does not require
oxygen [6,7].
Hypoxia occurs in joint inflammation such as during
the pathogenesis of rheumatoid arthritis [1,5], fracture
hematomas [8], and malignant tumors [9]. Ng et al.
demonstrated in recent in vivo studies that an inverse
correlation exists between synovial oxygen partial pres-
sure and inflammatory activity in patients with arthritis:
the stronger the inflammation, the more pronounced the
local hypoxia. Kennedy et al. showed anti-TNF-therapy,
widely used to treat RA, increases the oxygen partial
pressure in the joint. For the initial inflammatory envir-
onment in an early fracture hematoma, the specific cyto-
kine pattern and typical gene signatures in immune cells
reflect a situation of local hypoxia [8]. In addition, Vaupel
et al. showed the important role of hypoxia and hypoxia-
inducible factors (HIFs) in tumorigenesis [9].
During monocytopoiesis, monocyte precursor cells in
the bone marrow, monocytes in the blood and macro-
phages in the tissue are subjected to very different oxy-
gen levels. For example, an oxygen partial pressure
(pO2) of < 10 mmHg (1.3% O2) is present in the bone
marrow of mice [10]. In contrast, much higher pO2
values of 50 to 100 mmHg (6 to 13% O2) in the periph-
eral blood and of 20 to 50 mmHg (approximately 2.5 to
6.0% O2) in healthy tissue were measured [11]. Further-
more, in inflamed areas macrophages face pathophysio-
logical hypoxia. In these regions, the oxygen content is
lower than in healthy tissues because of imbalance
between provision and consumption of oxygen. Dis-
turbed blood circulation and inflammatory swellings
resulting in a lengthening of the diffusion distance
decrease the oxygen supply whereas the influx of meta-
bolically active immune cells strongly increases the oxy-
gen consumption [12]. For these reasons, cells are
forced to adapt immediately to the reduced pO2 levels
when entering these low oxygenated areas. The mechan-
ism of this adaptation and the temporal relationship of
this response to activation and migration are not yet
fully understood.
Rapid adaptation of monocytes to hypoxia may involve
HIF or other factors. In other cells (for example, T-cells),
it is known that the transcription factor HIF-1 under
hypoxic conditions is translocated into the nucleus and
binds to promoter regions of target genes to enable the
necessary adaptation and maintenance of basic functions
like motion, activation and effector cell function [12,13].
However, there are divergent views on the expression
and function of HIF in primary human monocytes.
Neither HIF-1a, HIF-2a nor HIF-3a were found by
Elbarghati et al. in primary monocytes after incubation
under hypoxia for 24 h. The authors suspected that the
a-subunit of HIF is not expressed, because the peripheral
blood as a place of residence of circulating monocytes is
characterized physiologically by a high pO2 [11,14]. How-
ever, it should be noted, that monocytes have to adapt to
lower oxygen levels immediately once they start the pro-
cess of being attracted to the vessel’s wall, migrating into
the inflamed tissue and starting to differentiate into
macrophages. CXCR4 transcript levels have been shown
to increase in monocytes facing hypoxia, which suggests
HIF is crucially involved in regulating the trafficking [15].
Furthermore, in myeloid cell lines like THP-1 cells incu-
bated under hypoxia, HIF-1a was detectable [16]. There
have also been reports that nuclear factor of kappa light
polypeptide gene enhancer in B-cells (NFB), a transcrip-
tion factor also regulated by hypoxia, is involved in the
adaptation of primary human monocytes to hypoxia [17].
Here we have examined how human monocytes adapt
to hypoxic conditions during their differentiation into
macrophages. We focused on the analysis of expression




PMA, macrophage colony stimulating factor 1 (hM-CSF),
and GÖ 6976 were purchased from Sigma Aldrich Che-
mie GmbH (Hamburg, Germany), ImmunoTools (Frie-
soythe, Germany), Merck KgaA (Darmstadt, Germany).
For toll like receptor (TLR) stimulation, hTLR ligand Set
II was bought from Apotech (Epalinges, Switzerland). For
immunoblotting, mouse monoclonal anti-HIF-1a anti-
body was bought from BD Transduction Laboratories
(Heidelberg, Germany); mouse anti-b-actin antibody was
purchased from Sigma-Aldrich (Hamburg, Germany);
goat polyclonal anti-HIF-2a, goat polyclonal anti-Lamin
B and mouse anti-Jun-B antibody were bought from
Santa Cruz Biotechnology (Heidelberg, Germany); mouse
monoclonal anti-NFB p100/p52, anti-NFB p105/p50,
anti-NFB p65, anti-c-Rel, anti-c-Fos, anti-c-Jun anti-
body were bought from Cell Signaling (Frankfurt/Main,
Germany); anti-mouse IgG HRP and anti-goat IgG HRP
were bought from Promega (Mannheim, Germany).
Monocyte isolation, culture and macrophage
differentiation
Human peripheral blood (buffy coats) was obtained
from healthy donors (DRK-Blutspendedienst Ost
gemeinnützige GmbH, Berlin/Brandenburg/Sachsen,
Germany, with approval from the Charité Ethics Review
Board). Peripheral blood mononuclear cells from these
buffy coats were then immediately isolated by density
gradient centrifugation using Ficoll-Paque™ Plus techni-
que (Amersham Bioscience AB, Freiburg, Germany). To
ensure a stable experimental setup and comparable
starting conditions, CD14+ monocytes were enriched up
to 99% purity and > 95% viability (data not shown) by
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MACS using anti-human CD14 conjugated magnetic
beads (Miltenyi Biotec, Bergisch Gladbach, Germany)
and then immediately used for the experiments. Mono-
cytes were cultured at 4 × 106cells/ml in RPMI 1640
supplemented with 10% volume/volume percent (v/v)
heat-inactivated FCS (Sigma-Aldrich, Hamburg,
Germany), 100 units/ml penicillin G, 100 μg/ml strepto-
mycin (both PAA Laboratories, Pasching, Austria), and
50 μM 2-ME (Sigma-Aldrich, Hamburg, Germany).
Monocytes were incubated with 25 nM hM-CSF for
7 days to differentiate into monocyte derived macro-
phages (hMDM).
Culture of cell lines
THP-1, HL-60, and U937 cells (American Type Culture
Collection) were cultured in Roswell Park Memorial Insti-
tute media (RPMI) 1640 supplemented with 10% (v/v)
heat-inactivated FCS, 100 units/ml penicillin G, 100 μg/ml
streptomycin, and 50 μM 2-ME. Human microvascular
endothelial cells (HMEC-1) were purchased from the Cen-
ter of Disease Control (Atlanta) and were cultivated in
endothelial basal medium (PAA Laboratories GmbH,
Pasching, Austria) supplemented with 5% (v/v) heat-inacti-
vated FCS (Sigma-Aldrich, Hamburg, Germany), 100
units/ml penicillin G, 100 μg/ml streptomycin (both PAA
Laboratories GmbH, Pasching, Austria), 1% (v/v) 200 mM
L-glutamine, 0,01% (v/v) endothelial growth factor (EGF)
(100 μg/ml), 0,2% (v/v) hydrocortisone (380 μM) (both
Sigma) and grown in 0.2% gelatine-coated 75 cm2 culture
flasks or 24-well plates, respectively.
Induction of hypoxia and stimulation
Cells were incubated in a humidified hypoxic chamber
(Binder, Tuttlingen, Germany) at 5% CO2 level and less
than 1% O2 balanced with N2. Normoxic controls were
incubated at 5% CO2 in a humidified atmosphere with
18% O2. Stimulation was done with PMA 10 ng/ml
(16 nM) (Sigma Aldrich Chemie GmbH, Hamburg,
Germany). For kinetic analyzes under hypoxia, monocytes
were incubated in a water-jacket chamber sealed with a
Clark-type oxygen electrode (Strathkelvin Instruments,
North Lanarkshire, Scotland) as described previously [12].
RNA isolation and quantitative real-time PCR (qPCR) of
selected genes
After cell lysis, total RNA was extracted (RNeasy Mini
Kit; Qiagen, Hilden, Germany) and the quality was
assessed on a Bioanalyzer (Agilent). The cDNA was
synthesized by reverse transcription using TaqMan®
Reverse Transcription Reagents (Applied Biosystems,
Darmstadt, Germany). qPCR was carried out using the
LightCycler® Fast Start DNA Master SYBR® Green I
Kit (Roche, Mannheim, Germany). Data were normal-
ized to the expression of b-actin (ACTB). All primers
used were obtained from TIB Molbiol (Berlin,
Germany): b-actin (ACTB), gACAggATgCAgAAggAgAT-
CACT, TgATCCACATCTgCTggAAggT; hypoxia-induci-
ble factor 1, alpha subunit (HIF1A), CCATTAgAAA
gCAgTTCCgC, TgggTAggAgATggAgATgC; lactate dehy-
drogenase A (LDHA), ACCCAgTTTCCACCATgATT,
CCCAAAATgCAAggAACACT; phosphoglycerate kinase
1 (PGK1), ATggATgAggTggTgAAAgC, CAgTgCTCA-




Cell lysis: for whole cell extracts of monocytes, 106 cells
were lysed in 20 μl Laemmli buffer. For the preparation of
nuclear/cytoplasmic fraction, 4*106 cells were lysed using
the Nuclear Extract Kit from Active Motif (La Hulpe,
Belgium), according to the manufacturer’s instructions.
Immunodetection of proteins: 20 μl of whole cell
extract or nuclear/cytoplasmic fraction was separated by
SDS-PAGE and blotted onto polyvinylidene difluoride
membranes (Millipore, Darmstadt, Germany). Blotted
proteins were analyzed as indicated and visualized by
enzymatic chemiluminescence (Amersham Biosciences,
Freiburg Germany).
Statistical analyzes
Data shown are reported as the mean ± SD of at least
six experiments. Differences between normally distribu-
ted groups were compared using the Student’s t-test and
in non-normally distributed groups with the Mann-
Whitney U-test for independent groups and with the
Wilcoxon t-test for dependent samples.
Results
HIF-1a is stabilised under hypoxia in human monocytes
but remains in the cytoplasm
In order to investigate first the stabilisation of HIF-1a as
a function of pO2 values and duration of incubation,
MACS-isolated CD14+ monocytes were incubated in a
Clark-type electrode for 5 h (Figure 1A) with a subse-
quent reoxygenation time of 12 minutes. Immunoblot
analyzes revealed that monocyte stabilisation of HIF-1a
begins when hypoxia (pO2 < 2%) commences. With
increasing duration of hypoxia, the accumulation of HIF-
1a increased (Figure 1B). There was marked accumula-
tion of HIF-1a during incubation under hypoxia. As
expected, reoxygenation caused an immediate degrada-
tion of HIF-1a (Figure 1B).
Next, we analyzed the cytosolic and nuclear fractions
after 5 h incubation, in order to define the exact loca-
tion of HIF-1a. HIF-1a was found exclusively in the
cytoplasm and not in the nuclear fraction of hypoxic
monocytes (Figure 1C).
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TLR stimulation does not affect HIF-1a localization
Following these observations, we investigated whether
concurrent TLR stimulation of human hypoxic monocytes
is needed for translocation of HIF-1a into the nucleus.
We incubated the cells for 5 h under hypoxia, with con-
current stimulation of TLR1-9 using a range of ligands
(Figure 2A). TLR stimulation under hypoxic conditions
did not lead to translocation of HIF-1a into the nucleus,
regardless of the ligand and concentration used. Represen-
tative experimental results are shown in Figure 2B-D,
obtained with Pam3CSK43HCl (toll-like receptor (TLR)-1/
2 stimulation), lipopolysaccharide LPS (TLR4 stimulation)
and R-848 (TLR7/8 stimulation). Under all hypoxic condi-
tions tested, HIF-1a was detectable exclusively in the cyto-
sol fraction of primary human monocytes.
PKC-a/b1 is essential for HIF-1a translocation
We examined whether stimulation with PMA leads to
translocation of HIF-1a into the nucleus. PMA is usually
applied to differentiate monocytes over a short time to a
macrophage-like phenotype. HIF-1a cannot be found in
unstimulated monocytes when incubated under nor-
moxia, as shown by immunoblot analyzes (Figure 3A).
However, if the cells were stimulated with PMA for 5 h
under normoxia, a weak HIF-1a signal in the cytosol
fraction was detectable. Although HIF-1a was detectable
under hypoxia in unstimulated monocytes exclusively in
the cytoplasm, in hypoxic PMA-stimulated monocytes it
was detectable not only in the cytoplasm, but also in the
nucleus. The signal strength of HIF-1a seen in hypoxic
PMA-stimulated cells was stronger than in hypoxic unsti-
mulated monocytes.
Since PMA is known to be a PKC activator, we incubated
monocytes for 5 h under hypoxia stimulated with PMA,
with concurrent addition of the PKC-a/b1- inhibitor,
Gö6976, at increasing concentrations. Figure 3B shows that
the inhibitor at a concentration of 50 nM reduced the
accumulation of HIF-1a in the nucleus. With a Gö6976
concentration of 100 nM, HIF-1a was no longer detectable
in the nucleus. These data demonstrate that PKC-a/b1 is
essential for the transport of HIF-1a from the cytoplasm
into the nucleus.
Monocyte differentiation to macrophages leads to HIF-1a
translocation
We considered whether differentiation of human mono-
cytes into macrophages (hMDMs) using hM-CSF also
caused hypoxia-induced translocation of HIF-1a into the
nucleus. The macrophage nuclear fraction was identified
using the location of Lamin B; the location of actin was
not used as this may be found in the nuclear fraction of
macrophages due to alterations in the cytoskeleton of
macrophages after stimulation, as described by Hartwig
and Janmey [18].
Incubation of monocytes with 25 nM hM-CSF over 7
days led to differentiation into hMDM. After incubation of
monocytes and hMDMs for 5 h under hypoxia, HIF-1a in
the monocytes could only be detected in the cytosolic
compartment, while in hMDMs HIF-1a was seen to reside
in the nuclear extract (Figure 4A).
We also considered whether any possible prior adhesion
of human monocytes to endothelial cells, as an initial step
of migration, could initiate the translocation of HIF-1a
into the nucleus. Human monocytes were incubated for 5
h in plates with wells coated with human microvascular
endothelial cells (HMEC-1), under hypoxia and under nor-
moxia. The cellular localization of HIF-1a was investi-
gated. We observed that co-culture with endothelial cells
of this type did not induce accumulation of HIF-1a in the
nucleus of the monocytes. HIF-1a was found exclusively
in the cytosol fraction of monocytes, as assessed by immu-
noblot (Figure 4B); HIF-1a was not detectable under nor-
moxia. Taken together, these findings suggest that
adhesion of monocyte to the vascular wall is not sufficient
for translocation of HIF-1a to the nucleus.
Hypoxia-induced gene expression of human monocytes
versus hMDMs
Next we compared the expression of selected hypoxia-
induced genes in human monocytes and hMDMs. We
Table 1 Primersets used
Gene symbol Gene name Gene function Primerset
ACTB beta-actin Structural housekeeper gACAggATgCAgAAggAgATCACT
TgATCCACATCTgCTggAAggT
HIF1A hypoxia-inducible factor 1, alpha subunit Transcription factor CCATTAgAAAgCAgTTCCgC
TgggTAggAgATggAgATgC








CXCR4 chemokine-receptor 4 chemokine-receptor ggCATgACggACAAgTACAggCT
AAAgTACCAgTTTgCCACggC
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examined genes that have been identified as typical HIF-
1 target genes such as the glycolysis enzymes LDHA and
PGK1, and the chemokine receptor CXCR4.
In monocytes incubated under hypoxic conditions - in
contrast to normoxia - genes for LDHA and CXCR4
were significantly (P < 0.05) upregulated, although HIF-
1a is not present in the nucleus; the gene for PGK1
showed increased expression but this did not reach sta-
tistical significance (Figure 5A-C). HIF1A as a target
gene of HIF-1 itself is regulated at the protein level and
Figure 1 Hypoxia-inducible factor alpha (HIF-1a) is stabilized under hypoxia but remains in the cytoplasm. (A) Scheme of sample
acquisition for kinetic analyzes of monocytes incubated in a water-jacket chamber sealed with a Clark-type oxygen electrode, which facilitates
the constant monitoring of oxygen saturation during the experimental setup (sample acquisition is indicated by arrows). (B) Detection of HIF-1a
and, for normalization purposes, b-actin in monocyte whole cell protein samples acquired as shown in (A) by immunoblot. Under hypoxia,
monocytes stabilize HIF-1a in a time-dependent manner. (C) Detection of HIF-1a, b-actin and for normalization purposes, the nuclear protein
Lamin B, in monocyte nuclear fraction (NF+) and cytosolic (NF-) cell fractions using immunoblot. HIF-1a was exclusively detected in the
cytoplasm in unstimulated monocytes incubated under hypoxic conditions (n = 6).
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therefore showed no measurable induction (Figure 5D).
Macrophages under normoxia showed higher expression
of the genes LDHA (1.7-fold) and PGK1 (2.3-fold) than
monocytes (Figure 5A and 5B). There was no significant
difference in the expression of these genes under
hypoxia versus normoxia, presumably because metabo-
lism had already been switched from oxidative phos-
phorylation/respiration to anaerobic glycolysis during
differentiation.
Similar findings were observed for CXCR4 (Figure 5C),
where hypoxic incubation did not lead to a significant
increase of CXCR4 expression in hMDMs. Also in
hMDMs, hypoxia did not induce any measurable upre-
gulation of HIF1A (Figure 5D).
Incubation of monocytes under hypoxia leads to
translocation of transcription factor NFB1 into the
nucleus
As the expression of HIF target genes (for example,
LDHA, CXCR4) in monocytes was induced by hypoxia
although HIF-1a was not present in the nucleus, we
considered other transcription factors that could be
involved.
We examined the cellular localization of transcription
factors NFB p100/p52, c-Rel, and c-Jun (Figure 6A),
NFBp105/p50 and c-Fos (Figure 6B), and Jun B and
NFB p65 (Figure 6C) in monocytes that were incu-
bated for 5 h under hypoxia. Although other transcrip-
tion factors (for example, c-Fos and NFB p65) did not
change their localization when incubated under hypoxic
versus normoxic conditions, NFBp105 (the inactive
form of NFB1) remained in the cytoplasm, while the
active form NFBp50 was translocated into the nucleus.
The active form of NFB2 (NFBp52) and c-Jun could
be seen in the nucleus under normoxic, but not under
hypoxic conditions.
THP-1, HL-60, and U937 cells express HIF-1a in the cell
nucleus under hypoxic and normoxic conditions
Myeloid cell lines are often used as an experimental
model for primary human monocytes. We considered in
which cellular compartment HIF-1a could be found in
Figure 2 Toll-like receptor (TLR) stimulation does not affect hypoxia-inducible factor alpha (HIF-1a) localization. (A) Table of TLRs and
their corresponding ligands used in our experiments within the given concentration range. (B-D) Detection of HIF-1a, Lamin B and b-actin in
monocyte nuclear (NF+) and cytosolic (NF-) cell fractions using immunoblot. Monocyte protein lysates were acquired after TLR stimulation and
incubation for 5 h under hypoxia using (B) TLR1/2 stimulation by Pam3CSK4 3HCl, (C) TLR4 stimulation by LPS or (D) TLR7/8 stimulation by R-
848.
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unstimulated and PMA-stimulated myeloid cell lines
(THP-1, HL-60, and U937) under hypoxic conditions.
We identified HIF-1a in the nucleus both under nor-
moxic and hypoxic conditions with or without PMA sti-
mulation (See Figure S1 A-C in Additional file 1). We
conclude that in this regard, the cell lines clearly differ
from primary human monocytes and behave like
hMDMs. This is of concern as these cell lines, but not
human monocytes, are routinely used for research on
bioenergetic issues (for example, adaptation to hypoxia).
Discussion
Circulating blood monocytes face oxygen concentrations
of more than 40 mmHg, which fuel oxidative phosphory-
lation. However, upon migration to inflamed joints,
monocytes encounter hypoxic conditions and must adapt
immediately to the reduced pO2. For several different cell
types, it has been shown that the transcription factor
HIF-1 under hypoxic conditions is translocated into the
nucleus where it binds to promoter regions of target
genes. This enables cells to adapt and maintain their
basic and specific functions [19,20]. Elbarghati et al.
reported recently that primary human macrophages but
not monocytes rapidly up-regulate HIF-1a and HIF-2a
proteins upon exposure to hypoxia, with translocation of
these proteins into the nucleus [14].
We demonstrate here that the transcription factor HIF-
1a also accumulates in quiescent human monocytes
under hypoxia, but is present solely in the cytosol. For
this reason, we postulate that it cannot be responsible for
the transcriptional induction of typical hypoxia target
genes in the nucleus. It is not clear why monocytes differ
in this regard from many other cell types, where HIF-1a
under hypoxia is translocated into the nucleus [21-25].
One possibility is that the HIF-induced adaptation
mechanism in monocytes is not necessary because of the
plentiful oxygen supply present in peripheral blood. The
stabilisation of HIF-1a in the cytosol under hypoxic con-
ditions may, therefore, reflect a pre-active state that
becomes active when the cells start their migration into
low oxygen tissue areas. However, it should be noted that
we also studied quiescent and PHA-stimulated peripheral
Figure 3 Protein kinase (PKC)-a/b1 is essential for hypoxia-inducible factor alpha (HIF-1a) translocation. (A+B) Detection of HIF-1a,
Lamin B and b-actin in nuclear (NF+) and cytosolic (NF-) cell fractions of primary human monocytes using immunoblot. (A) Monocyte protein
lysates were acquired after PMA stimulation and incubation for 5 h under hypoxia and under normoxia as indicated. (B) Monocyte protein
lysates were acquired after PMA stimulation following PKC-a/b1 inhibition using Gö6976 as indicated and subsequent incubation for 5 h under
hypoxia. (A, B) PMA stimulation for 5 h under hypoxia leads to nuclear translocation of HIF-1a, and specific inhibition of PKC-a/b1 by Gö6976
prevents translocation of HIF-1a.
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human blood CD3+CD4+ T-cells, which also circulate in
oxygen-rich blood. In contrast to monocytes, hypoxic
conditions induced HIF-1a in these cells, with transloca-
tion into the nucleus as shown by immunoblotting [12].
From this observation, we suggest that the HIF-1a regu-
lation mechanism may be a feature of the evolutionary
younger cells of the adaptive immune system, but not of
evolutionary older cells of the innate immune system,
such as monocytes.
The apparent lack of involvement of HIF-1a in regu-
lating expression of hypoxia-induced genes in mono-
cytes suggests that other transcription factors mediate
this effect. In the literature, it has been reported that
adaptive responses to hypoxia are regulated by several
transcription factors, including HIF-1, HIF-2, ETS-1,
cAMP response element binding protein, activator pro-
tein-1 and nuclear factor-B [26-33]. Hence, we exam-
ined various possible transcription factors and found
that the active form of NFB1, NFBp50, is translocated
into the nucleus of the human monocytes as a reaction
towards a pO2 of < 2%. In good agreement with this
observation, Battaglia et al. have previously shown DNA
binding of NFBp50 under hypoxia in primary human
monocytes by means of a supershift analysis [17].
Furthermore, Oliver et al. have described the selective
activation of the canonical NF-B pathway via p65 by
intermittent and sustained hypoxia in HeLa cells [34].
The non-canonical NF-B pathway via p52 is not
impacted by hypoxia. Our results are consistent with
these findings as we show, to our knowledge for the
first time in primary monocytes, that p50 is part of the
canonical pathway induced by sustained hypoxia.
We therefore suggest that NFB1 serves as a key reg-
ulator enabling the immediate adaptation of monocytes
to hypoxia during migration from blood into the tissue
environment. We suggest that, during the differentiation
Figure 4 Hypoxia-inducible factor alpha (HIF-1a) translocation after differentiation of monocytes to macrophages and co-culture with
endothelial cells. (A, B) Detection of HIF-1a, Lamin B and b-actin in monocyte or hMDM nuclear (NF+) and cytosolic (NF-) cell fractions using
immunoblot. (A) Protein lysates were acquired after incubation of human monocytes and hMDM for 5 h under hypoxia. Differentiation of
monocytes to macrophages leads to HIF-1a translocation into the nucleus. (B) Monocyte protein lysates were acquired after incubation of
human monocytes on human endothelial cells (HMEC-1, human microvascular endothelial cells) coated well plates for 5 h under normoxia and
under hypoxia. Co-culture of monocytes with endothelial cells is not sufficient for the translocation of HIF-1a.
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process of human monocytes into macrophages, the
more potent and possibly more robust HIF-1 system is
activated. The HIF-1 system may be needed for the
rapid adaptation to varying oxygen concentrations,
which is of essential functional importance for long-liv-
ing tissue macrophages. Indeed, we demonstrate here
that the stimulation of the monocytes with PMA (which
although non-physiological is usually applied to differ-
entiate monocytes over a short time to a macrophage-
like phenotype) and the more physiological induction of
monocyte differentiation by means of M-CSF cause the
translocation of HIF-1a into the nucleus of long-living
tissue macrophages. The presence of HIF-1a in the
nucleus of macrophages or hMDMs under hypoxia has
already been verified by other groups [14,35-37]. HIF-1a
was also detectable in the nucleus of different myeloid
cell lines (THP-1, HL-60, and U937) under hypoxic con-
ditions. Although often used as experimental models of
monocytes, these cell line cells are highly proliferative
and malignant cells with numerous differences from
macrophages, hMDMs, and monocytes. With regard to
the HIF-1 pathways, these cell lines behave like macro-
phages or hMDMs, but not like monocytes. This should
be considered when using these cell lines as models to
analyze the bioenergetic functions of monocytes and/or
macrophages in inflammatory arthritis.
Our observation that both PMA stimulation and M-
CSF-induced differentiation of monocytes into macro-
phages causes the translocation of HIF-1a into the
nucleus prompted a search for potential regulators.
Figure 5 Monocytes, in contrast to human monocyte derived macrophages (hMDMs), show hypoxia-induced gene expression. Real-
time PCR analysis of mRNA expression levels of the glycolytic enzymes LDHA (A) and PGK1 (B), the hypoxia inducible factor (HIF)-1 target gene
CXCR4 (C) and the transcription factor HIF1A (D) in monocytes and hMDM that were incubated under normoxia (white bars) and under hypoxia
(black bars), respectively (n = 6). The mRNA expression level of ß-actin (ACTB) was used for normalization. ΔCt = Ct(GOI) - Ct(ACTB). Values are
means ± SD. +P < 0.1;* P < 0.05; (Wilcoxon t-test).
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Since PKC-a/b1 is strongly activated by PMA stimula-
tion, we hypothesized that this protein kinase enzyme
could play a key role. Indeed, our experiments demon-
strated that the inhibition of PKC by Gö6976 leads to
abrogation of HIF-1a translocation into the nucleus.
Our observation is in agreement with data provided by
Chang and Beezhold who have proved the existence of
both prevailing PKC-isoforms a and b in primary
human monocytes [38]. Lin et al. recently showed
Gö6976-mediated inhibition of PKC-a and membrane
translocation during differentiation into MDMs, and
consequently diminished differentiation of MDMs [39].
It should be noted, however, that the exact mechanism
of the PKC-mediated transport of HIF-1a into the
nucleus is currently still unclear.
It was interesting to realize that HIF-1a is not shifted
into the nucleus if human monocytes are incubated under
hypoxia with concurrent TLR stimulation. Furthermore,
contact of monocytes with endothelial cells (that is,. the
initial migration step and therefore the beginning of the
differentiation) is not sufficient to induce HIF-transloca-
tion. Taken together, these data clearly demonstrate that
neither the contact of monocytes with antigen in the
hypoxic areas nor the contact of monocytes with endothe-
lial cells causes the translocation of HIF-1a into the
nucleus; rather, it appears to be the differentiation process
per se that activates the HIF-1 system.
In agreement with Bosco et al. [40], we showed that
hypoxia strengthens the genetic expression of the glyco-
lysis enzyme LDHA. HIF-1a is not present in the
nucleus under these conditions so we infer this effect to
be mediated by NFBp50. However, macrophages
demonstrate significantly higher expressions of the gene
LDHA (and another enzyme involved in glycolysis,
PGK1) under normoxia than monocytes. In addition, the
expression of these genes is not increased by incubating
macrophages under hypoxic conditions (LDHA P = 0.39,
PGK P = 0.26). A constitutional PKC over-expression
constantly inducing the HIF-1 system may be a possible
explanation of these observations [41].
Interestingly, the observations made for the glycolysis
genes differ from those for the chemokine receptor
CXCR4. It should be noted that the expression of this
chemokine receptor is oxygen-dependent. Therefore, the
chemotactic behaviour of monocytes can be adapted to
variable oxygen conditions. Bosco et al. described a
genetic induction of CXCR4 in a transcriptome charac-
terisation of monocytes incubated under hypoxia [40].
We also found the CXCR4 gene in monocytes to be sig-
nificantly induced under hypoxia. However, in contrast
to glycolysis genes, the CXCR4 gene expression under
normoxia in hMDMs is not more pronounced than in
monocytes. Although CXCR4 expression increased in
hMDMs with hypoxia, this increase was not significant
(P = 0.17). A significant increase in the genetic expres-
sion for CXCR4 under hypoxia in hMDMs has been
described by Fang et al. [42]. Schioppa et al. showed
that in human monocytes and human MDMs, hypoxia
induced expression of CXCR4 at the protein level [15].
The authors interpret the navigation process hypoxia/
HIF-1/CXCR4 as an important mechanism for the regu-
lation of cell migration into hypoxic tissues or for the
retention of cells in hypoxic tissues. This is in line with
our finding of hypoxia/HIF-1/CXCR4 for hMDMs but,
due to the absence of HIF-1a in the nucleus of mono-
cytes, as hypoxia/NFBp50/CXCR4 for monocytes.
Figure 6 Incubation of monocytes under hypoxia leads to translocation of transcription factor, nuclear factor of kappa light
polypeptide gene enhancer in B-cells (NFB1), into the nucleus. Detection of hypoxia-inducible factor alpha (HIF-1a), Lamin B and b-actin
in nuclear (NF+) and cytosolic (NF-) cell fractions of primary human monocytes using immunoblot. (A-C) Monocyte protein lysates were acquired
after incubation for 5 h under hypoxia and under normoxia as indicated. The cellular localization of transcription factors NFB p100/p52, c-Rel,
and c-Jun (Figure 6A), NFBp105/p50 and c-Fos (Figure 6B), and Jun B and NFB p65 (Figure 6C) were determined by immunoblot. NFBp105
(the inactive form of NFB1) remains in the cytoplasm, while the active form NFBp50 is translocated into the nucleus under hypoxic conditions
(Figure 6B). Other factors showed either no change in their localization or, as for c-Jun and NFBp52, were no longer translocated into the
nucleus under hypoxic incubation.
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Conclusions
In summary, the localization of the transcription factor
HIF-1a is shifted during the differentiation process from
the cytosol (in monocytes) to the nucleus (in macro-
phages), apparently as a PKC-a/b1- mediated adaptation
to a low oxygen environment. In monocytes, it is
NFkB1, and not HIF-1a, that is of central importance
for the expression of hypoxia-adjusted genes. These data
demonstrate that (i) during differentiation crucial cellu-
lar adaptation mechanisms are decisively changed and
(ii) bioenergetic aspects are of crucial importance for
the understanding of underlying pathophysiological pro-
cesses in inflammatory arthritis.
Additional material
Additional file 1: Figure S1 A-C. Myeloid cell lines (THP-1, HL-60,
and U937) express HIF-1a in the cell nucleus. THP-1 cells (A), HL-60
cells (B) and U937 cells (C) express HIF-1a in the nucleus under
normoxia and hypoxia, with or without PMA stimulation (5 h). THP-1 and
U937 show similar expression of HIF-1a under normoxia and hypoxia (A,
C), whereas HL-60 cells demonstrate increased expression of hypoxia-
inducible factor (HIF)-1a under hypoxia (B). All cell lines show a higher
expression of HIF-1a in the presence of PMA (A-C). Detection of HIF-1a,
Lamin B and b-actin in nuclear (NF+) and cytosolic (NF-) cell fractions of
myeloid cell lines using immunoblot. (A-C) Protein lysates were acquired
after incubation for 5 h under hypoxia and under normoxia as indicated.
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